| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.0M | -48.6% |
| Cost of Revenue | $1.4M | -30.7% |
| Gross Profit | $1.7M | -57.4% |
| R&D Expense | $1.8M | -35.5% |
| SG&A Expense | $6.3M | +27.8% |
| Operating Income | -$8.8M | -22.8% |
| Net Income | -$7.8M | -19.6% |
| EPS (Basic) | -$3.96 | +36.8% |
| EPS (Diluted) | -$3.96 | +36.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.4M | -17.6% |
| Accounts Receivable | $193K | -62.8% |
| Inventory | $1.3M | -13.6% |
| Current Assets | $15.0M | -28.0% |
| Total Assets | $15.3M | -28.5% |
| Current Liabilities | $1.0M | -18.4% |
| Total Liabilities | $1.0M | -24.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.1M | -17.1% |
| Capital Expenditures | $184K | +0.0% |
| Investing Cash Flow | $5.3M | +362.5% |
| Financing Cash Flow | $1.5M | -36.5% |
| Free Cash Flow | -$7.3M | -16.6% |
| Stockholders' Equity |
| $14.3M |
| -28.8% |